Cancer chemotherapy and somatic cell mutation (Q34057953)

30 July 2017

1 reference

title

Cancer chemotherapy and somatic cell mutation (English)

1 reference

30 July 2017

1 reference

Kubota M

1

1 reference

30 July 2017

Lin YW

2

1 reference

30 July 2017

Hamahata K

3

1 reference

30 July 2017

Sawada M

4

1 reference

30 July 2017

Koishi S

5

1 reference

30 July 2017

Hirota H

6

1 reference

30 July 2017

Wakazono Y

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

470

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

93-102

1 reference

Survivors of childhood cancer and risk of a second tumor

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

International Commission for Protection Against Environmental Mutagens and Carcinogens. Working paper no. 3. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Human somatic mutation assays as biomarkers of carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Somatic-cell mutations as a possible predictor of cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Enumeration of 6-thioguanine-resistant peripheral blood lymphocytes in man as a potential test for somatic cell mutations arising in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Measurement of in vivo mutations in human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

A fast and simple method to determine the clonal relationship among human T-cell lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

The effect of T-lymphocyte ‘clonality’ on the calculated hprt mutation frequency occurring in vivo in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Measurement of spontaneous and X-irradiation-induced 6-thioguanine-resistant human blood lymphocytes using a T-cell cloning technique.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Mutation frequency in human blood cells increases with age

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Spontaneous loss and alteration of antigen receptor expression in mature CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Frequencies of HPRT mutants and micronuclei in lymphocytes of cancer patients under chemotherapy: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Analysis of hprt gene mutation following anti-cancer treatment in pediatric patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Biomarkers in long survivors of pediatric acute lymphoblastic leukemia patients: late effects of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Second neoplasms after acute lymphoblastic leukemia in childhood.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

The effect of chemotherapy on the in vivo frequency of glycophorin A 'null' variant erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Glycophorin A mutations and risk of secondary leukaemia in patients treated for childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

The assessment of in vivo somatic mutations in survivors of childhood malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Somatic mutations at T-cell antigen receptor and glycophorin a loci in pediatric leukemia pateints following chemotherapy: comparison with HPRT locus mutation

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Somatic mutations at the T-cell antigen receptor in antineoplastic drug-exposed populations: comparison with sister chromatid exchange frequency.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Intercorrelations and sources of variability in three mutagenicity assays: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Human in vivo somatic mutation measured at two loci: individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

In vivo mutations in human blood cells: biomarkers for molecular epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Hprt mutations and karyotype abnormalities in T-cell clones from healthy subjects and melphalan-treated ovarian carcinoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Adriamycin induces large deletions as a major type of mutation in CHO cells

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

The frequency of illegitimate V(D)J recombinase-mediated mutations in children treated with etoposide-containing antileukemic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Evaluation of mutant frequencies at the hprt and the T-cell receptor loci in pediatric cancer patients before treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Mutant frequency at the hprt locus in human lymphocytes in a case-control study of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Evidence for increased somatic cell mutations in patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Increased frequency of somatic mutations at glycophorin A loci in patients with aplastic anaemia, myelodysplastic syndrome and paroxysmal nocturnal haemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

1 reference

7 January 2021

Elevated hprt mutant frequency in circulating T-lymphocytes of xeroderma pigmentosum patients

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Molecular analysis of mutations in the hprt gene in circulating lymphocytes from normal and DNA-repair-deficient donors

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Somatic cell mutation frequency at the HPRT, T-cell antigen receptor and glycophorin A loci in Cockayne syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Cloning Efficiency and Spontaneous Mutant Frequency in Circulating T-lymphocytes in Ataxia-telangiectasia Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Frequencies of HPRT− lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Evidence for increased in vivo mutation and somatic recombination in Bloom's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

In vivo somatic mutations in Werner's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

BCL2 translocation frequency rises with age in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

High frequency of etoposide (VP-16)-related secondary leukemia in children with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Pharmacogenetics and cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Application of pharmacogenetics to optimization of mercaptopurine dosing

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Thymidine kinase deficient cells with decreased TTP pools are hypersensitive to DNA alkylating agents

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Determinants of O(6)-alkylguanine-DNA alkyltransferase activity in normal and tumour tissue from human colon and rectum

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

Second malignancy following treatment of acute lymphoblastic leukemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5742%2800%2900043-0

7 January 2021

10.1016/S1383-5742(00)00043-0

Identifiers

DOI

1 reference

30 July 2017

1 reference